Canada markets closed

Kymera Therapeutics, Inc. (KYMR)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
38.44+0.14 (+0.37%)
At close: 04:00PM EDT
38.43 -0.01 (-0.03%)
After hours: 05:16PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
78,592
78,592
46,826
72,832
34,034
Operating Expenses
Research Development
189,081
189,081
164,248
137,017
62,105
Selling General and Administrative
55,041
55,041
43,834
36,345
18,233
Total Operating Expenses
244,122
244,122
208,082
173,362
80,338
Operating Income or Loss
-165,530
-165,530
-161,256
-100,530
-46,304
Interest Expense
196
196
176
175
115
Income Before Tax
-146,962
-146,962
-154,808
-100,217
-45,593
Income from Continuing Operations
-146,962
-146,962
-154,808
-100,217
-45,593
Net Income
-146,962
-146,962
-154,808
-100,217
-45,593
Net Income available to common shareholders
-146,962
-146,962
-154,808
-100,217
-54,643
Basic EPS
-2.86
-
-2.87
-2.09
-3.15
Diluted EPS
-2.86
-
-2.87
-2.09
-3.15
Basic Average Shares
58,218
-
53,933
47,989
17,350
Diluted Average Shares
58,218
-
53,933
47,989
17,350